Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Taro Pharmaceutical Industries?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Taro Pharmaceutical Industries market cap is $1.62B.
What is the 52-week high for Taro Pharmaceutical Industries?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Taro Pharmaceutical Industries 52 week high is $45.76 as of September 06, 2025.
What is the 52-week low for Taro Pharmaceutical Industries?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Taro Pharmaceutical Industries 52 week low is $32.67 as of September 06, 2025.
What is Taro Pharmaceutical Industries stock price today?
Taro Pharmaceutical Industries stock price today is $42.97.
What was Taro Pharmaceutical Industries stock price yesterday?
Taro Pharmaceutical Industries stock price yesterday was $42.97.
What is the PE ratio of Taro Pharmaceutical Industries?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Taro Pharmaceutical Industries’s P/E ratio is 29.98.
What is the Price-to-Book ratio of Taro Pharmaceutical Industries?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Taro Pharmaceutical Industries P/B ratio is 0.9078.
What is the 50-day moving average of Taro Pharmaceutical Industries?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Taro Pharmaceutical Industries 50-day moving average is $42.50.
